IL20RB Antikörper

Produktnummer ABIN2568247

Produktdetails anti-IL20RB Antikörper

Target: IL20RB (Interleukin 20 Receptor beta (IL20RB))

Reaktivität: Human, Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser IL20RB Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunocytochemistry (ICC), Flow Cytometry (FACS)

Spezifität: The 20RNTC monoclonal antibody specifically reacts with human and mouse interleukin-20 receptor 2 (IL-20R2 or IL-20Rb).

Aufreinigung: The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.

Klon: 20RNTC

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered aqueous solution, ≤0.09 % Sodium azide, may contain carrier protein/stabilizer, ph7.2.

Lagerung: 4 °C

Informationen zur Lagerung: The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze.

Details zu IL20RB

Target: IL20RB (Interleukin 20 Receptor beta (IL20RB))

Andere Bezeichnung: IL-20 Receptor 2 (IL20RB Produkte)

Synonyme: DIRS1 antikoerper, FNDC6 antikoerper, IL-20R2 antikoerper, AV228068 antikoerper, Fndc6 antikoerper, Gm186 antikoerper, Il20R2 antikoerper, IL20R2 antikoerper, RGD1566151 antikoerper, interleukin 20 receptor subunit beta antikoerper, interleukin 20 receptor beta antikoerper, IL20RB antikoerper, Il20rb antikoerper

Hintergrund: The 20RNTC monoclonal antibody specifically reacts with human and mouse interleukin-20 receptor 2 (IL-20R2 or IL-20Rb). IL-20R2 is a class II cytokine receptor that pairs with IL-20R to form a receptor capable of binding IL-19, IL-20, or IL-24 and binds IL-20, or IL-24 when paired with IL-22R1. It is primarily found on epithelial originated cells such as those found in the skin or intestines.

Gen-ID: 53833, 213208

UniProt: Q6UXL0

Pathways: Regulation of Leukocyte Mediated Immunity